Yuxintong Capsule
Function and Efficacy
The results of preclinical animal experiments indicate that intraduodenal administration of this product can reduce the degree and range of myocardial ischemia in dogs with ligation of the left anterior descending coronary artery, reduce the area of myocardial infarction, and increase coronary blood flow in anesthetized dogs; intragastric administration can reduce blood viscosity in rats and inhibit platelet adhesion.
Ingredients
Corydalis yanhusuo, red ginseng, Panax notoginseng.
Appearance
This product is a capsule, the contents are brown to brown powder; it has a slight odor and a slightly bitter taste.
Usage and Dosage
Oral administration. 4 capsules each time, 3 times a day. The course of treatment is 4 weeks.
Adverse Reactions
A very small number of patients experience local rash, nausea and vomiting after taking the medicine.
Precautions
Not yet clear
Drug Interactions
Not yet clear
Storage
Keep away from light and store in a sealed container.
Packaging Specification
0.33g per tablet
Validity Period
24 months
Manufacturer
Dalian Shengguang Pharmaceutical Group Co., Ltd.
-
Founded in:
2002-09-06 -
Address:
No. 477, Lvshun North Road (Sanjian Section), Lvshunkou District, Dalian City, Liaoning Province -
Tax NO.:
912102007409328152 -
Registered Funds:
62 million yuan -
Email: